|
1
|
Genetic/familial high-risk assessment: breast and ovarian.
|
J Natl Compr Canc Netw
|
2010
|
2.45
|
|
2
|
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
|
J Natl Cancer Inst
|
2012
|
1.48
|
|
3
|
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
|
J Natl Compr Canc Netw
|
2014
|
1.48
|
|
4
|
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.25
|
|
5
|
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.03
|
|
6
|
Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference?
|
Ann Surg Oncol
|
2015
|
0.97
|
|
7
|
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
|
Breast Cancer Res Treat
|
2014
|
0.93
|
|
8
|
Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.92
|
|
9
|
High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis.
|
Genet Med
|
2012
|
0.91
|
|
10
|
Spectrum of dolichospondylic dysplasia: two new patients with distinctive findings.
|
Am J Med Genet
|
2002
|
0.91
|
|
11
|
Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.
|
J Genet Couns
|
2013
|
0.88
|
|
12
|
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.
|
Carcinogenesis
|
2007
|
0.86
|
|
13
|
Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.
|
Genet Test Mol Biomarkers
|
2014
|
0.85
|
|
14
|
Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
|
J Cancer Educ
|
2013
|
0.84
|
|
15
|
Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
|
Breast Cancer Res Treat
|
2015
|
0.84
|
|
16
|
Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned.
|
J Community Genet
|
2010
|
0.83
|
|
17
|
Development of a brochure for increasing awareness of inherited breast cancer in black women.
|
Genet Test Mol Biomarkers
|
2011
|
0.82
|
|
18
|
Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women.
|
Am J Med Genet A
|
2010
|
0.80
|
|
19
|
A pilot study to examine patient awareness and provider discussion of the impact of cancer treatment on fertility in a registry-based sample of African American women with breast cancer.
|
Support Care Cancer
|
2012
|
0.80
|
|
20
|
Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.
|
Genet Test Mol Biomarkers
|
2012
|
0.80
|
|
21
|
Contrasting the ethical perspectives of biospecimen research among individuals with familial risk for hereditary cancer and biomedical researchers: implications for researcher training.
|
Genet Test Mol Biomarkers
|
2014
|
0.79
|
|
22
|
Risk factors for ovarian cancers with and without microsatellite instability.
|
Int J Gynecol Cancer
|
2014
|
0.77
|
|
23
|
Retracted
Risk factors for ovarian cancers with and without microsatellite instability.
|
Int J Gynecol Cancer
|
2013
|
0.77
|
|
24
|
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.
|
Anticancer Res
|
2012
|
0.77
|
|
25
|
International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers.
|
Ann Surg Oncol
|
2013
|
0.77
|
|
26
|
Risk terminology in biobanking and genetic research: what's in a name?
|
Am J Med Genet A
|
2013
|
0.75
|
|
27
|
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
|
Cancer
|
2004
|
0.75
|
|
28
|
Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?
|
J Genet Couns
|
2014
|
0.75
|
|
29
|
The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of Accomplishments.
|
J Health Care Poor Underserved
|
2022
|
0.75
|